Vito Coviello

FOXD1–ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells

Peng Cheng, Jia Wang, Indrayani Waghmare et al. · Cancer Research · 2016 · 182 citations · Full text

Transcriptional Regulation, Developmental Biology, Foxd1–aldh1a3 Signaling +14

Imidazo[1,2-<i>a</i>]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells

Luca Quattrini, Edoardo Luigi Maria Gelardi, Vito Coviello et al. · Journal of Medicinal Chemistry · 2020 · 61 citations · Full text

Nanostructured ultra-thin patches for ultrasound-modulated delivery of anti-restenotic drug

Lorenzo Vannozzi, Leonardo Ricotti, Carlo Filippeschi et al. · International Journal of Nanomedicine · 2015 · 33 citations · Full text

Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells

Daisuke Yamashita, Mutsuko Minata, Ahmed N. Ibrahim et al. · Molecular Cancer Therapeutics · 2020 · 33 citations · Full text

Tumor Biology, Breast Oncology, Viable Therapeutic Target +15

Cyclodextrin-based nanosponges for the targeted delivery of the anti-restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous intervention

Vito Coviello, Stefania Sartini, Luca Quattrini et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2017 · 27 citations · Full text

Nanomedicine, Engineering, Anti-restenotic Agent Db103 +10